2020-01-01
Widespread protein lysine acetylation in gut microbiome and its alterations in patients with Crohn’s diseaseAbout
Karen Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease, four years before the first published case study.
Recent Posts
2019-01-01
Variation of Gut Mucosal Microbiome With Anti-Saccharomyces cerevisiae Antibody Status in Pediatric Crohn Disease2019-01-01
Altered microbiomes distinguish Alzheimer’s disease from amnestic mild cognitive impairment and health in a Chinese cohort2018-01-01
Analysis of endoscopic brush samples identified mucosa-associated dysbiosis in inflammatory bowel disease2018-01-01
Modulation of faecal metagenome in Crohn’s disease: Role of microRNAs as biomarkers2018-01-01
Fecal microbial dysbiosis in Chinese patients with inflammatory bowel disease2017-01-01
Gut Microbiome Function Predicts Response to Anti-integrin Biologic Therapy in Inflammatory Bowel Diseases2016-01-01
Gut microbiota in early pediatric multiple sclerosis: a case-control study2016-01-01
Alterations of the human gut microbiome in multiple sclerosis2016-01-01
Microbiome Survey of the Inflamed and Noninflamed Gut at Different Compartments Within the Gastrointestinal Tract of Inflammatory Bowel Disease Patients2016-01-01
Multiple sclerosis patients have a distinct gut microbiota compared to healthy controls2016-01-01
Reduced Abundance of Butyrate-Producing Bacteria Species in the Fecal Microbial Community in Crohn’s Disease2015-01-01
Dysbiosis in the Gut Microbiota of Patients with Multiple Sclerosis, with a Striking Depletion of Species Belonging to Clostridia XIVa and IV Clusters2014-01-01
The treatment-naive microbiome in new-onset Crohn’s disease